Alpine Immune Sciences Announces Participation in Fireside Chat at the 5th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced participation in the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, at 12:35 p.m. ET. The event will feature a fireside chat, and a live webcast will be accessible in the investor relations section of the company's website. A replay will also be available for 90 days post-event. Alpine is dedicated to innovative immunotherapy development and has a diverse pipeline of clinical candidates, alongside strategic collaborations with leading biopharmaceutical companies.

Positive

• Participation in the 5th Annual Evercore ISI HealthCONx Conference could enhance visibility and investor interest.
• Alpine maintains a diverse pipeline of clinical and preclinical candidates, indicating growth potential.

Negative

• None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will participate in a fireside chat at the 5^th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022, at 12:35 p.m. ET/9:35 a.m. PT.

A live webcast of the fireside chat will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the live event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005816/en/

Temre Johnson (Investors)

Alpine Immune Sciences, Inc.

ir@alpineimmunesciences.com

Kelli Perkins (Media)

Red House

kelli@redhousecomms.com

Source: Alpine Immune Sciences, Inc.

FAQ

What is Alpine Immune Sciences' participation in the Evercore ISI HealthCONx Conference?

Alpine Immune Sciences will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022.

Where can I watch the live webcast of the Alpine Immune Sciences fireside chat?

The live webcast will be available in the investor relations section of Alpine Immune Sciences' website.

How long will the replay of the Alpine Immune Sciences fireside chat be available?

A replay of the fireside chat will be available on the company's website for 90 days after the live event.

What is the focus of Alpine Immune Sciences?

Alpine Immune Sciences focuses on developing innovative immunotherapies for autoimmune and inflammatory diseases.

What is the ticker symbol for Alpine Immune Sciences?

The ticker symbol for Alpine Immune Sciences is ALPN.